Immuron Ltd — Regulatory Filings 2006

Aug 8, 2006

August 9th, 2006

Company Announcement Office Australian Stock Exchange Ltd (ASX) 4^th Floor, 20 Bridge Street Sydney NSW 2000

Dear Sir/Madam

Please find herewith a company announcement "Renewal of Aussie Bodies Contract" for release and distribution to the market immediately.

Yours sincerely

CONOR GRAHAM Managing Director & CEO

Aussie Bodies Contract Signed

Anadis is pleased to announce the signing of a two year manufacturing contract with Aussie Bodies, a division of Health Brands Australia. Anadis will continue to manufacture the majority of Aussie Bodies supplement and slimming products from our facility in Campbellfield Melbourne.

Aussie Bodies has been a major contributor to toll manufacturing since the establishment of our contract manufacturing facility over 5 years ago.

It is with considerable satisfaction that Anadis is able to announce the continuation of this relationship for the next two years.

Under the new banner of "Health Brands Australia", the number of products manufactured for Aussie Bodies and other Health Brands brand names, by Anadis has increased. It is expected that this product portfolio will continue to expand, especially for these additional brands in the coming months.

We look forward to continue to supply premium quality products for Health Brands Australia, the gateway for some of the most trusted brands in health nutrition and supplementation.

More information about Aussie Bodies can be found at http://www.aussiebodies.com.au and Health Brands Australia at http://www.healthbrands.com.au.

For further information, please contact:

Conor Graham - Chief Executive Officer Email: conor.g@anadis.com.au +61 3 9358 6388

Arie Nudel - Investor Relations Email: arie.n@anadis.com.au +61 3 9358 6388

About Anadis Limited:

Anadis, a Melbourne based biopharmaceutical company is focused on Nutraceutical and Pharmaceutical research and development. Anadis is a specialist in the development of bovine colostrum derived products for therapeutic use in humans. Projects include:

Anadis' first commercialised product: Travelan is a natural product, which significantly decrease the risk of the medical condition known as Travellers Diarrhoea and the symptoms of gastrointestinal disorders. Travelan is a bovine colostrum preparation, prepared from cows hyper-immunized against the 13 most common strains of E, coli – the most common cause of Travellers Diarrhoea (Bali Belly, Delhi Belly, etc.).

Travelan has recently received a "Green Light' for sales in the US and a distributor in Canada has been appointed. Travelan is being considered for other markets including: Singapore, India, Korea, United Arab Emirates, Thailand, Malaysia, South Africa and the UK and EU.

Travelan has recently been potentially identified for additional gastrointestinal indications including Irritable Bowel Syndrome IBS and Inflammatory Bowel Disorder IBD.

For more information please visit www.travelan.com.au

EV-71 - a bioactive protein based preventative product against Enterovirus 71, a debilitating polio like disease, is one of the viruses that causes 'hand, foot and mouth' or 'slapped cheek' disease. A significant proportion of younger children effected can develop nervous signs such as fits, paralysis and Enterovirus 71 has the potentially to be fatal.

A set of Bio-Warfare/Respiratory Protection technologies, a project in conjunction with the Australian Department of Defence and US Bio-Defence Organisations, initially focused on short-term immediate protection from airborne bacteria such as Anthrax and Plague, future civilian applications include Hay .
Fever and Asthma.

Bio-Shield 10 a range of "bio-shielding" technologies which protect delicate molecules, enzymes and proteins, initially targeted for use in the pro-biotic market.

Development into an Immune Stimulating Infant Formula is underway, initially destined for the Asian market.

Pyloran, which has been clinically proven to reduce levels of H.pylori bacteria in the stomach and reduce the symptoms of H.pylori associated gastritis - Anadis is also in early development of a H.pylori vaccine.

Visit our websites: www.anadis.com.au and www.travelan.com.au

Anadis - Delivering On The Promise Of Biotechnology